Big Pharma continues with announced employee layoffs, could partly be due to redirection with biotech investments as indicated in recent news events. BD
Schering-Plough will cut a minimum of 500 jobs starting on August 11th in New Jersey as part of a much larger plan to layoff 5,500 employees across the globe. At the same time, Johnson & Johnson will send about the same number of employees packing when it cuts nearly 300 jobs nationwide and shifts 260 positions out of New Jersey. The Schering-Plough layoffs will be mainly be at its Kenilworth facility, but will also affect facilities in Berkeley Heights, Roseland, Springfield, Summit and Union. The shifted J&J positions will move to Pennsylvania and will become part of the company's Centocor subsidiary following a merger of the unit with its Ortho-Biotech unit.
0 comments :
Post a Comment
Click to see the code!
To insert emoticon you must added at least one space before the code.